Sign up for the QMED & MD+DI Daily newsletter.
Remolding a Leader
January 1, 2003
1 Min Read
Originally Published MX January/February2003
Interview by Steve Halasey
Martin D. Madaus,
Leadership counts--andnot just on the bottom line. Company leadership can influence the direction of amarketplaceand its investors,making available resources that would otherwise have gone into other sectors orindustries. And personal leadership can encourage companies to take onchallenges well beyond those of an already competitive marketplace.
But don't take our word for it. Ask Martin D. Madaus, president and CEO ofRoche Diagnostics Corp. (Indianapolis), the leader in the global market for invitro diagnostics (IVDs). Rising through the ranks at Boehringer Mannheim(acquired by Roche in 1997), Madaus took over the helm of the company in January2000. He arrived with a clear notion of the kind of company he wanted to lead,and rapidly set about putting his changes in motion.
Madaus's efforts have paid off in the company's bottom line--and elsewhere.During the past year, Roche has repeatedly grabbed top honors at a wide varietyof awards presentations. In December, the company's e-business unit received
You May Also Like
Sustainable Manufacturing Expo Hits North AmericaFeb 22, 2024|4 Min Read
Medtronic Doubles Down on Sustainability EffortsFeb 22, 2024|1 Min Read
Top Medical Device M&AFeb 21, 2024|1 Min Read
FDA Urges Independent Verification of Third-Party Testing DataFeb 21, 2024|2 Min Read